Revelation Biosciences- Warrants(10/01/2027) Accounts Payable

As of the most recent data (June 2026), REVBW shows a accounts payable of $930K. That compares with $830K in the prior-year period — up 12.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, REVBW's accounts payable is now $930K (was $830K) — a 12.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Revelation Biosciences- Warrants(10/01/2027) is outperforming or lagging.

Tracking REVBW's accounts payable over time shows whether Revelation Biosciences- Warrants(10/01/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $930K That compares with $830K in the prior-year period — up 12.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Revelation Biosciences- Warrants(10/01/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $930K) with ownership activity and broader fundamentals.